Posted in

Pompe Disease

Amicus Provides Updates on AT-GAA for Pompe Disease

January 7, 2020

The Assistance Fund Opens New Program for Pompe Disease

January 7, 2020

Amicus Announces Positive Data in Phase 1/2 Study of AT-GAA at World Muscle Society

October 2, 2019

Amicus and Catalent Biologics Enter Partnership for Gene Therapy Development and Manufacturing

July 2, 2019

Amicus and Brammer Bio Enter Gene Therapy Development and Manufacturing Collaboration

July 1, 2019

Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL in Pompe

December 20, 2018

Accelerated Approval Denied & Study Underway for Pompe Treatment

September 10, 2018

UF & MDA Host 2018 Pompe Disease Patient Meeting

July 30, 2018

Developing Personalized CRISPR-Cas9 Genome Editing Therapy for Pompe Disease

July 18, 2018

Amicus Announces Regulatory/Clinical Updates for AT-GAA in Pompe

July 6, 2018